It's actually the opposite of moving forward , it's ripping down , don't believe your own BS
Geron Imetelstat is a drug being developed to possibly cure people , there's plenty to bet on , shorting a potential life saving drug is simply wrong ! There's no guarantees , but J&J is one of the largest pharmaceutical Co s in the world & they are involved in studies , so they obviously see something , I'll go with them.
Shorting a small Co with the support of a giant Pharm is prob not a good idea , and bad karma. Jmho
Market Data 
Markets 
AI
